AstraZeneca (LON:AZN) Stock Rating Reaffirmed by Berenberg Bank

Berenberg Bank reiterated their buy rating on shares of AstraZeneca (LON:AZN) in a report released on Monday morning, MarketBeat Ratings reports. The brokerage currently has a £150 ($191.69) price target on the biopharmaceutical company’s stock.

Several other analysts also recently issued reports on AZN. Jefferies Financial Group increased their price objective on shares of AstraZeneca from GBX 71 ($0.91) to GBX 74 ($0.95) and gave the company a hold rating in a research report on Tuesday, July 2nd. Shore Capital reiterated a buy rating on shares of AstraZeneca in a research note on Thursday, July 25th. Deutsche Bank Aktiengesellschaft reiterated a hold rating and set a £110 ($140.58) target price on shares of AstraZeneca in a research note on Tuesday, June 18th. JPMorgan Chase & Co. reiterated an overweight rating on shares of AstraZeneca in a research note on Tuesday, June 4th. Finally, Citigroup reiterated a buy rating on shares of AstraZeneca in a research note on Tuesday, May 28th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of Moderate Buy and a consensus target price of £105.53 ($134.87).

AstraZeneca Stock Up 2.4 %

AZN opened at £126.28 ($161.38) on Monday. The firm has a 50 day moving average price of £123.22 and a 200 day moving average price of £114.03. The company has a market cap of £195.73 billion, a PE ratio of 4,047.44, a price-to-earnings-growth ratio of 0.97 and a beta of 0.16. AstraZeneca has a 1 year low of GBX 9,461 ($120.91) and a 1 year high of £127.84 ($163.37). The company has a debt-to-equity ratio of 92.51, a quick ratio of 0.59 and a current ratio of 0.89.

AstraZeneca Cuts Dividend

The business also recently declared a dividend, which will be paid on Monday, September 9th. Investors of record on Thursday, August 8th will be given a GBX 77.60 ($0.99) dividend. The ex-dividend date of this dividend is Thursday, August 8th. This represents a dividend yield of 0.64%. AstraZeneca’s dividend payout ratio (DPR) is 7,307.69%.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.